2005P-0411
  

  
 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs 

  


  

  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC1688
  



  

  
Submitter : 
  

  
Dr. Michael Lee
  

  
Date & Time: 
  

  
02/13/2006 01:02:40
  



  

  
Organization : 
  

  
Dr. Michael Lee
  



  

  
Category : 
  

  
Health Professional
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 The huge and constantly expanding volume of reliable data regarding bioidentical hormone replacement for women cannot be ignored. Any advice given to women to bypass this particular treatment regimen is at best premature and at worse unethical and not in the patient's best interest.